Syncom Formulations (India) Limited (NSE:SYNCOMF)
India flag India · Delayed Price · Currency is INR
17.95
-0.09 (-0.50%)
Sep 12, 2025, 3:30 PM IST

Syncom Formulations (India) Company Description

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally.

It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments.

The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms.

It also provides life care, evolve, and the right nutrition products under the Cratus brand. In addition, the company offers its pharmaceutical formulation products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent.

Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.

Syncom Formulations (India) Limited
CountryIndia
Founded1988
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees998
CEOVijay Bankda

Contact Details

Address:
Syncom House
Indore, 452018
India
Phone91 73 1270 0458
Websitesyncomformulations.com

Stock Details

Ticker SymbolSYNCOMF
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE312C01025
SIC Code2834

Key Executives

NamePosition
Vijay Shankarlal Bankda B. Com LLBMD and Executive and Non Independent Director
Vaishali AgrawalCompany Secretary and Compliance Officer
Rakesh Ch. SrivastavaChief Marketing Officer
Kedarmal Shankarlal Bankda M.ComWhole-Time Director
Rahul Vijay BankdaChief Financial Officer and President of Domestic Marketing
Payal Ankur BankdaVice President of Human Resources
Ankur Vijay BankdaPresident of Export Marketing